HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudia Palena Selected Research

CD58 Antigens (LFA-3)

10/2010Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells.
6/2009Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.
5/2008Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudia Palena Research Topics

Disease

68Neoplasms (Cancer)
01/2022 - 05/2003
27Carcinoma (Carcinomatosis)
02/2021 - 05/2003
12Neoplasm Metastasis (Metastasis)
08/2021 - 04/2007
6Lung Neoplasms (Lung Cancer)
01/2020 - 07/2012
6Vaccinia
01/2020 - 02/2005
5Chordoma
01/2021 - 03/2015
5Breast Neoplasms (Breast Cancer)
01/2020 - 05/2014
4Prostatic Neoplasms (Prostate Cancer)
01/2021 - 08/2007
4Infections
06/2016 - 07/2004
3Sarcoma (Soft Tissue Sarcoma)
01/2022 - 10/2015
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2010 - 11/2005
3Fowlpox
05/2008 - 07/2004
2Squamous Cell Carcinoma of Head and Neck
01/2020 - 03/2006
2Triple Negative Breast Neoplasms
11/2017 - 10/2016
2Adenocarcinoma
10/2015 - 07/2012
2Mesothelioma
10/2015 - 09/2005
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2021
1Pheochromocytoma
08/2021
1Human Influenza (Influenza)
01/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2020
1Chondrosarcoma
01/2019
1Diarrhea
11/2017
1Carcinogenesis
10/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2017

Drug/Important Bio-Agent (IBA)

29VaccinesIBA
02/2021 - 05/2003
26Brachyury protein (Brachyury)IBA
01/2021 - 04/2007
22AntigensIBA
02/2021 - 08/2003
19Transcription Factors (Transcription Factor)IBA
01/2021 - 04/2007
10Cancer VaccinesIBA
02/2021 - 11/2004
10Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2004
9Interleukin-8 (Interleukin 8)IBA
01/2021 - 08/2011
9Peptides (Polypeptides)IBA
01/2019 - 05/2003
8ChemokinesIBA
01/2021 - 09/2005
8EpitopesIBA
01/2017 - 05/2003
8Carcinoembryonic AntigenIBA
10/2015 - 05/2003
6Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
6Neoplasm Antigens (Tumor Antigens)IBA
01/2020 - 02/2005
5CytokinesIBA
01/2020 - 08/2011
5HLA-A2 Antigen (HLA A2 Antigen)IBA
12/2014 - 03/2004
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2010 - 07/2004
3LigandsIBA
01/2022 - 04/2016
3Pharmaceutical PreparationsIBA
10/2021 - 01/2014
3smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
01/2021 - 08/2019
3Monoclonal AntibodiesIBA
01/2019 - 03/2015
3Docetaxel (Taxotere)FDA Link
11/2017 - 08/2013
3PerforinIBA
04/2016 - 03/2006
3CD58 Antigens (LFA-3)IBA
10/2010 - 05/2008
3lymphotactinIBA
08/2007 - 11/2003
2Interleukin-12 (IL 12)IBA
01/2022 - 01/2019
2Histone Deacetylase InhibitorsIBA
01/2022 - 01/2020
2entinostat (MS 275)IBA
01/2022 - 01/2020
2Interleukin-15 (Interleukin 15)IBA
02/2021 - 01/2019
2B7 AntigensIBA
08/2019 - 11/2017
2HuMax-IL8IBA
01/2019 - 11/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2017 - 06/2012
2AutoantigensIBA
11/2017 - 05/2003
2Messenger RNA (mRNA)IBA
10/2016 - 05/2014
2Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2016 - 01/2016
2ErbB Receptors (EGF Receptor)IBA
07/2016 - 07/2012
2Granzymes (Granzyme)IBA
04/2016 - 08/2007
2TamoxifenFDA LinkGeneric
03/2015 - 05/2014
2Phosphotransferases (Kinase)IBA
05/2014 - 07/2012
2CD40 Ligand (CD40L)IBA
10/2010 - 07/2004
2Biological ProductsIBA
03/2006 - 01/2006
1Programmed Cell Death 1 ReceptorIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1CollagenIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Interferon-gamma (Interferon, gamma)IBA
01/2022
1GemcitabineFDA Link
10/2021
1MannansIBA
08/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Cadherins (E-Cadherin)IBA
01/2020
1Transforming Growth Factor beta (TGF-beta)IBA
01/2020
1Ado-Trastuzumab EmtansineIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1TNF-Related Apoptosis-Inducing LigandIBA
01/2018
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
12/2017
1ClaudinsIBA
11/2017
1Cytotoxins (Cytolysins)IBA
01/2017
1Estrogens (Estrogen)FDA Link
12/2016
1Estrogen Receptor alphaIBA
12/2016
1Fulvestrant (Faslodex)FDA Link
12/2016
1Estrogen Receptor AntagonistsIBA
12/2016
1Estrogen ReceptorsIBA
12/2016
1Phenobarbital (Luminal)FDA Link
10/2016
1p38 Mitogen-Activated Protein KinasesIBA
07/2016
1Gefitinib (Iressa)FDA Link
07/2016

Therapy/Procedure

33Therapeutics
01/2022 - 08/2003
21Immunotherapy
08/2021 - 11/2004
17Drug Therapy (Chemotherapy)
01/2021 - 01/2006
2Radiotherapy
05/2014 - 01/2014
1Intravenous Administration
01/2021
1Castration
01/2021
1Duration of Therapy
01/2019